 Diabetic retinopathy non-insulin-dependent diabetes mellitus patients role gliclazide Diabetic retinopathy common cause human blindness ages industrialized world Retinopathy multifactorial etiology Standard treatment glucose metabolism partial amelioration certain hemobiologic factors addition metabolic action gliclazide specific hemobiologic properties studies gliclazide animals humans significant improvements platelet abnormalities stimulation prostaglandin synthesis enhancement fibrinolytic activity humans open-label studies gliclazide treatment stabilization background retinopathy non-insulin-dependent diabetics beneficial effects controlled studies months sulfonylureas Japanese Diabetic Retinopathy Program progression retinopathy period gliclazide sulfonylureas placebo study equivalent metabolic control trend rate deterioration incidence preproliferative retinopathy group sulfonylureas Overall specific hemobiologic actions gliclazide progression diabetic retinopathy advantage incidence preproliferative retinopathy